New Path

Hindsight is a great thing.
The revenue potential with FDA approval grade results still remains blue sky.

I see a new path ahead.

The professor has purchased more shares and is over in states planning.
Long tern holders still in place with top 20 unchanged
New Research team appointed.
Pre recording education on app
New prerecording noise checks.
Regular Education for staff in ED's
Recordings to be checked regularly to hear if all recordings done properly and rejected if not.

We now await new Hospital IRB approvals and any further strategy improvements.

MB